Biotechnology and Biopharmaceuticals
Transforming Proteins and Genes into Drugs
Click here to join our rewards scheme and earn points on this purchase!
Release Date: 22/11/2013
Transforming Proteins and Genes into Drugs The essential single source on drug discovery and biotechnology products—newly revised and updated Since the first edition of Biotechnology and Biopharmaceuticals was published, biotechnology has continued to drive therapeutic product development. The majority of new medicines coming on the market today are developed based on tools created by biotechnology—and healthcare providers who are concerned with optimum drug therapy need to understand the principles underlying the discovery, development, and application of these biological drugs and therapies of the future. Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, Second Edition addresses the pivotal issues relating to translational science, including preclinical and clinical drug development, regulatory science, pharmaco-economics, and cost-effectiveness considerations. It provides research pharmacologists, biopharmaceutical R&D personnel, toxicologists, and biotechnologists with cutting-edge research on new proteins and genetic medicines, the translational and integrated sciences that continue to fuel the innovations in medicine, as well as the new areas of therapeutic development, including cancer vaccines, stem cell therapeutics, and cell-based therapies. Presented in three parts, and containing several appendices, Biotechnology and Biopharmaceuticals: Ideal for research pharmacologists, biopharmaceutical R&D personnel, toxicologists, and biotechnologists, Biotechnology and Biopharmaceuticals will also appeal to clinical pharmacologists, pharmacists, physicians, and health scientists
The essential single source on drug discovery and biotechnology products, Biotechnology and Biopharmaceuticals addresses the pivotal issues relating to translational science, including preclinical and clinical drug development, regulatory science, pharmaco-economics, and cost-effectiveness considerations.